Purchase Order 75D30123P17062
- Not listed
- This firm fixed-price purchase order was awarded to Emory University, a private research institution in Atlanta, Georgia, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The $90,000.00 contract is for an IRB-approved study under the Emory University Center for AIDS Research. The contract has no set-aside designation and is set to be completed by September 20, 2022. Emory University, through its Office of Sponsored Programs Division, has an extensive track record of...
- This is a $75,616 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia, for the collection and delivery of blood specimens. The contract has a period of performance through May 17, 2023 and does not include a set-aside designation. Emory University is the prime contractor and there is no information provided about any subcontractors. As a major recipient of federal...
- This is a $243,120 firm fixed-price purchase order contract awarded to Emory University by the Centers for Disease Control and Prevention (CDC) for the EMORY - ANTIRETROVIRAL SPECIMEN STUDY. The contract has an ultimate completion date of August 31, 2026 and is not set aside. Emory University, a private research institution in Atlanta, Georgia, is conducting this biomedical research study through its Office of Sponsored Programs division. The contract work involves developing, refining, and...
- This contract was awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Emory University's Office of Sponsored Programs Division. The contract, titled "DOXY STUDY", is a firm fixed-price purchase order with a potential value of $240,497.00 and a completion date of August 31, 2022. The contract does not have a set-aside designation. Under this contract, Emory University will provide services related to the DOXY STUDY in Atlanta,...
- This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for $125,123.27 in firm fixed-price laboratory analysis services. It has a completion date of September 15, 2023. Emory University is the prime contractor on this contract, which is not set aside for any specific socioeconomic category. Emory is a major recipient of federal research contracts and grants,...
- This $571,955.88 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for serological testing services and does not have a set-aside designation. Emory University has an extensive track record of performing federally funded research and providing services to government agencies through contracts and grants, including in areas such as infectious disease...
- This is a $695,773 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university located in Atlanta, Georgia. The contract is for an MSM PREP STUDY with a performance period through September 22, 2023. The contract does not have a set-aside designation. Emory University is an experienced federal contractor, having received numerous prime contracts and subcontracts from agencies such as the Department of...
- This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Emory University, a private research university located in Atlanta, Georgia. The contract is for laboratory analysis services with a firm fixed price of $77,297.50 and a completion date of September 14, 2023. Emory University has an extensive track record of performing federally funded research and providing services to the government, including work for the CDC...
- This is a $245,000 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia. The contract, titled "EMORY-SARS COV2 CRYIEM," is for research and services related to the COVID-19 virus. The contract has an ultimate completion date of August 30, 2024. Emory University is a major recipient of federal contracts and grants, particularly in the areas of biomedical...
- This is a $107,120.64 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for a study on obesity and immunity, with a performance period that runs through August 13, 2024. Emory University, through its Office of Sponsored Programs division, is a major recipient of federal research contracts and grants, with a focus on biomedical research, public health, and...
This is a $248,999.00 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University for a study of biological specimens from persons receiving daily oral doxycycline. The contract has an ultimate completion date of August 31, 2025. Emory University is a private research university located in Atlanta, Georgia, known for its expertise in biomedical research, public health, and healthcare innovation. The contract is not set aside for any specific socioeconomic category, indicating Emory's technical capabilities and competitiveness in securing federal contracts. Emory University has a history of collaborating with various federal agencies, including the National Institutes of Health, Defense Health Agency, and CDC, on advanced research initiatives across multiple healthcare domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 3/15/24 | |
| P00002 | Funding Only Action | $0 | 9/18/23 | |
| P00001 | Other Administrative Action | $0 | 9/7/23 | |
| Not listed | Not listed | $249.0k | 8/29/23 |